https://www.amylyx.com/daily1.0 https://www.amylyx.com/image/als-patient-in-motorized-chair-with-family-member-and-dog2021-09-30T11:19Znever https://www.amylyx.com/image/headshot-of-paul-fonteyne-02021-12-09T07:14Znever https://www.amylyx.com/image/headshot-of-als-wife-caregiver-and-advocate2021-12-09T07:35Znever https://www.amylyx.com/image/amylyx-leadership-team-smiling-standing-next-to-each-other2021-10-07T06:09Znever https://www.amylyx.com/image/headshot-of-person-living-with-als-32021-12-09T07:36Znever https://www.amylyx.com/image/white-logo-of-pegasus-02021-12-09T11:41Znever https://www.amylyx.com/image/white-logo-of-centaur-12021-12-09T13:05Znever https://www.amylyx.com/image/graphic-displaying-the-combination-of-pb-and-turso-and-its-impact-on-cortical-neuronal-viability-02021-12-10T05:32Znever https://www.amylyx.com/image/white-logo-of-centaur-22021-12-13T04:37Znever https://www.amylyx.com/image/als-patient-in-motorized-chair-with-family-member-and-dog-32021-12-13T05:44Znever https://www.amylyx.com/image/headshot-of-josh-cohen-12024-11-30T07:42Znever https://www.amylyx.com/image/amylyx-co-founder-and-co-ceo-justin-klee2024-12-20T11:46Znever https://www.amylyx.com/image/group-photo-of-amylyx-team-standing-on-stairs-together-outdoors-wearing-face-masks2021-12-02T11:33Znever https://www.amylyx.com/image/headshot-of-daphne-quimi-02021-12-14T06:56Znever https://www.amylyx.com/image/zoomed-in-microscopic-view-of-mitochondria-showing-late-stage-neuron-death-02021-12-14T14:39Znever https://www.amylyx.com/image/zoomed-in-microscopic-view-of-mitochondria-showing-early-stage-neuron-death-02021-12-14T14:40Znever https://www.amylyx.com/image/map-of-the-united-states-displaying-locations-of-the-centaur-trial-02021-12-15T06:02Znever https://www.amylyx.com/image/collage-of-photos-of-amylyx-team-members2021-10-11T05:17Znever https://www.amylyx.com/image/headshot-of-daphne-quimi-12021-12-15T13:08Znever https://www.amylyx.com/image/headshot-of-paul-fonteyne-12021-12-15T13:08Znever https://www.amylyx.com/image/man-smiling-in-the-foreground-with-a-notecard-on-his-forehead-with-other-participants-in-the-activity-in-the-background-02023-05-05T10:12Znever https://www.amylyx.com/image/everything-als-logo2021-12-16T04:54Znever https://www.amylyx.com/image/headshot-of-debra-canner-02021-12-16T06:01Znever https://www.amylyx.com/image/headshot-of-james-m-frates-02021-12-16T06:03Znever https://www.amylyx.com/image/headshot-of-tom-holmes-02021-12-16T06:06Znever https://www.amylyx.com/image/headshot-of-margaret-olinger-12021-12-16T06:07Znever https://www.amylyx.com/image/canada-flag-02021-12-16T06:22Znever https://www.amylyx.com/image/us-flag2021-12-16T06:22Znever https://www.amylyx.com/image/logo-for-i-am-als-02021-12-17T04:05Znever https://www.amylyx.com/image/white-logo-of-centaur2021-10-07T07:54Znever https://www.amylyx.com/image/graph-displaying-the-als-functional-rating-scale-alsfrs-r-total-at-week-24-in-the-centaur-trial-02021-12-17T06:00Znever https://www.amylyx.com/image/amx0035-pipeline-upcoming-milestones-22021-12-17T06:01Znever https://www.amylyx.com/image/amx0035-pipeline-upcoming-milestones-32021-12-17T06:01Znever https://www.amylyx.com/image/logo-for-i-am-als-12021-12-17T07:51Znever https://www.amylyx.com/image/graph-displaying-the-als-functional-rating-scale-alsfrs-r-total-at-week-24-in-the-centaur-trial-12021-12-23T05:21Znever https://www.amylyx.com/image/usa-flag-02022-01-13T10:48Znever https://www.amylyx.com/image/canada-flag-12022-01-13T10:49Znever https://www.amylyx.com/image/netherlands-flag-02022-01-13T10:50Znever https://www.amylyx.com/image/logo-for-phoenix-trial-with-white-background-and-blue-detail2021-11-12T03:58Znever https://www.amylyx.com/image/headshot-of-debra-canner-12022-02-09T14:48Znever https://www.amylyx.com/image/josh-cohen2024-12-02T17:23Znever https://www.amylyx.com/image/gina-mazzariello-bio-photo2022-02-23T00:17Znever https://www.amylyx.com/image/amylyx-co-founder-and-co-ceo-josh-cohen2024-12-20T11:48Znever https://www.amylyx.com/image/amx0035-pipeline-graphic2022-02-25T13:11Znever https://www.amylyx.com/image/amx0035-pipeline-graphic-02022-02-25T13:12Znever https://www.amylyx.com/image/amylyx-chief-legal-office-gina-mazzariello2025-01-14T06:49Znever https://www.amylyx.com/image/amylyx-logo-12022-03-01T12:23Znever https://www.amylyx.com/image/white-logo-of-pegasus2021-12-02T10:45Znever https://www.amylyx.com/document/amylyx-code-of-business-conduct-and-ethics-pdf2026-01-22T03:36Zyearly https://www.amylyx.com/remote-videos/mechanism-of-disease2022-03-11T23:58Znever https://www.amylyx.com/remote-videos/mechanism-of-disease-02022-03-12T00:02Znever https://www.amylyx.com/image/pipeline-graphic2022-03-15T04:17Znever https://www.amylyx.com/document/RELYVRIO-US-Prescribing-Information.pdf2022-09-30T16:21Znever https://www.amylyx.com/image/medical-icon2022-05-10T11:14Znever https://www.amylyx.com/image/amx0035-pipeline-graphic-12022-06-03T17:40Znever https://www.amylyx.com/image/amx0035-pipeline-graphic-22022-06-03T17:41Znever https://www.amylyx.com/image/amx0035-pipeline-graphic-32022-06-13T11:54Znever https://www.amylyx.com/image/amx0035-pipeline-graphic-42022-06-13T11:55Znever https://www.amylyx.com/image/logo-for-amylyx-in-white-circle-with-blue-detail2021-10-07T11:12Znever https://www.amylyx.com/document/asent-2021pdf2022-08-29T14:11Znever https://www.amylyx.com/document/RELYVRIO-US-Medication-Guide.pdf2022-09-30T16:20Znever https://www.amylyx.com/document/cnsf-2022-eposterfinal0pdf2022-09-12T18:58Znever https://www.amylyx.com/document/icnmd-2022-final-eposterpdf2022-09-12T18:59Znever https://www.amylyx.com/document/mda-scientific-conference-2017-poster0pdf2022-09-12T18:59Znever https://www.amylyx.com/document/neals-2020pdf2022-09-12T18:59Znever https://www.amylyx.com/document/neals-oral-presentationpdf2022-09-12T19:00Znever https://www.amylyx.com/document/phoenix-neals-posterfinalpdf2022-09-12T19:00Znever https://www.amylyx.com/image/amylyx-care-team2022-09-21T10:22Znever https://www.amylyx.com/image/laughing-als-patient-in-motorized-chair-next-to-smiling-caregiver-22021-10-11T05:15Znever https://www.amylyx.com/image/amx0035-pipeline-graphic-52022-11-11T04:46Znever https://www.amylyx.com/image/amx0035-pipeline-graphic-62022-11-11T04:46Znever https://www.amylyx.com/image/timeline-of-amylyxs-path-to-progress-12022-09-26T05:09Znever https://www.amylyx.com/image/image-of-timeline-graph2022-09-26T05:10Znever https://www.amylyx.com/image/timeline-of-amylyxs-path-to-progress-22022-09-26T05:10Znever https://www.amylyx.com/image/relyvrio-logo-02022-09-28T06:11Znever https://www.amylyx.com/remote-videos/amyoriginsfinal2022-10-13T11:12Znever https://www.amylyx.com/image/the-amylyx-story2022-10-13T12:01Znever https://www.amylyx.com/image/tricals-logo2022-10-21T05:13Znever https://www.amylyx.com/relyvrio-us-colorado-wac-disclosure.pdf2024-03-05T16:20Znever https://www.amylyx.com/document/Amylyx_HCP_Privacy_Notice_28Oct2022.pdf2022-11-14T05:35Znever https://www.amylyx.com/document/development-and-preclinical-assessment-of-antisense-oligonucleotides-targeting-calpain-2.pdf2022-12-20T05:57Znever https://www.amylyx.com/document/development-of-aso-targeting-calpain-2.pdf2022-12-20T05:56Znever https://www.amylyx.com/document/improvement-in-a-plasma-biomarker-of-neuroinflammation.pdf2022-12-20T05:53Znever https://www.amylyx.com/document/real-world-strategies-to-enhance-the-palatability-of-coformulated-sodium-phenylbutyrate-and-taurursodiol-for-the-treatment-of-amyotrophic-lateral-sclerosis.pdf2022-12-20T05:42Znever https://www.amylyx.com/document/mnda-2022-centaur-cardiac-aes-poster.pdf2023-01-11T03:59Znever https://www.amylyx.com/document/mnda-2022-eap-updates-and-learnings-poster.pdf2023-01-11T03:59Znever https://www.amylyx.com/document/mnda-2022-phoenix-update-poster.pdf2023-01-11T03:59Znever https://www.amylyx.com/image/phoenixdeskto2023-02-01T23:36Znever https://www.amylyx.com/image/phoenixmobile2023-02-01T23:37Znever https://www.amylyx.com/image/karen-firestone2023-03-13T20:27Znever https://www.amylyx.com/image/post-phoenixpipelinedesktop2023-03-13T20:35Znever https://www.amylyx.com/image/post-phoenixpipelinemobile2023-03-13T20:36Znever https://www.amylyx.com/document/Amylyx_HCP_Privacy_Notice_German_24March2023.pdf2023-03-27T05:42Znever https://www.amylyx.com/document/Amylyx_Consent_Form_HCP_24March2023.pdf2023-03-27T05:43Znever https://www.amylyx.com/document/Amylyx_Consent_Form_HCP_German_24March2023.pdf2023-04-10T08:26Znever https://www.amylyx.com/document/Amylyx_HCP_Privacy_Notice_22Mar2023.pdf2023-03-28T05:51Znever https://www.amylyx.com/document/Amylyx_Consent_Form_HCP_French_Digital_22March2023.pdf2023-03-31T05:39Znever https://www.amylyx.com/document/Amylyx_Consent_Form_HCP_French_Paper_22March2023.pdf2023-03-31T05:39Znever https://www.amylyx.com/document/Amylyx_HCP_Privacy_Notice_French_22Mar2023.pdf2023-03-31T05:40Znever https://www.amylyx.com/document/mda-2023-calpain-poster.pdf2023-04-05T13:39Znever https://www.amylyx.com/image/icon-globe2023-04-03T04:16Znever https://www.amylyx.com/image/icon-globe-02023-04-03T04:17Znever https://www.amylyx.com/image/flag-united-states2023-04-03T08:18Znever https://www.amylyx.com/image/flag-uk2023-04-03T08:18Znever https://www.amylyx.com/image/flag-eu2023-04-03T08:18Znever https://www.amylyx.com/image/flag-canada2023-04-03T08:19Znever https://www.amylyx.com/image/wspipelinedesktop2023-04-13T13:21Znever https://www.amylyx.com/image/wspipelinemobile2023-04-13T13:22Znever https://www.amylyx.com/image/wspipeline-page-graphic041323desktop2023-04-19T13:39Znever https://www.amylyx.com/image/wspipeline-page-graphic041323mobile2023-04-19T13:40Znever https://www.amylyx.com/image/pipeline-graphic-02023-05-11T20:13Znever https://www.amylyx.com/image/pipeline-graphic-12023-05-11T20:13Znever https://www.amylyx.com/image/pipeline-graphic-22023-05-11T20:14Znever https://www.amylyx.com/image/pipeline-graphic-32023-05-11T20:15Znever https://www.amylyx.com/image/collage-of-photos-of-amylyx-team-members-02021-10-11T05:16Znever https://www.amylyx.com/document/tides-2023-poster.pdf2023-05-25T15:56Znever https://www.amylyx.com/document/ispor-2023-poster.pdf2023-05-25T15:55Znever https://www.amylyx.com/image/smiling-als-patient-in-motorized-chair-next-to-smiling-caregiver-22021-10-12T05:52Znever https://www.amylyx.com/document/Amylyx-HCP-Privacy-Notice-Italian-20June2023.pdf2023-06-22T05:01Znever https://www.amylyx.com/document/Amylyx-HCP-Privacy-Notice-Spanish-20June2023.pdf2023-06-22T05:01Znever https://www.amylyx.com/document/encals-phoenix-poster-final.pdf2023-07-12T16:02Znever https://www.amylyx.com/document/encals-preclinical-data-poster-final.pdf2023-07-12T16:03Znever https://www.amylyx.com/image/pipeline-graphic-42023-09-08T20:38Znever https://www.amylyx.com/image/pipeline-graphic-52023-09-08T20:38Znever https://www.amylyx.com/image/pipeline-graphic-62023-09-11T18:50Znever https://www.amylyx.com/image/pipeline-graphic-72023-09-11T18:51Znever https://www.amylyx.com/image/pipeline-graphic-82023-09-11T18:53Znever https://www.amylyx.com/image/pipeline-graphic-92023-09-11T19:00Znever https://www.amylyx.com/image/amx0035-pipeline-upcoming-milestones2021-10-12T10:01Znever https://www.amylyx.com/image/pipeline-graphic-102023-09-11T19:06Znever https://www.amylyx.com/document/neals-2023-and-mnda-2023-amylyx-taste-survey-posterfinal.pdf2023-10-05T21:18Znever https://www.amylyx.com/document/neals-2023-feeding-tube-posterfinal.pdf2023-10-05T21:23Znever https://www.amylyx.com/document/neals-2023-planned-studies-posterfinal.pdf2023-10-05T21:19Znever https://www.amylyx.com/document/neals-2023-umichigan-calpain-poster.pdf2023-10-05T21:20Znever https://www.amylyx.com/document/neals-2023-us-eap-poster.pdf2023-10-05T21:20Znever https://www.amylyx.com/document/neals-aso-calpain-poster.pdf2023-10-05T21:21Znever https://www.amylyx.com/document/neals-diagnostic-biomarker-posterfinal.pdf2023-10-05T21:24Znever https://www.amylyx.com/image/pipeline-graphic-112023-10-11T19:33Znever https://www.amylyx.com/image/zoom-call-screenshot-with-all-members-showing-als-tattoos-for-inkedforals2021-10-12T14:56Znever https://www.amylyx.com/image/pipeline-graphic-122023-10-13T12:40Znever https://www.amylyx.com/image/pipeline-graphic-132023-10-16T13:51Znever https://www.amylyx.com/document/psp-neuro-2023-poster.pdf2023-10-19T13:06Znever https://www.amylyx.com/image/pipeline-graphic-142023-10-21T00:46Znever https://www.amylyx.com/image/pipeline-graphic-152023-10-21T00:47Znever https://www.amylyx.com/document/Proteomic-Analyses-in-the-24-Week-PEGASUS-Trial.pdf2023-10-24T12:48Znever https://www.amylyx.com/document/rethinking-economic-evaluation-in-amyotrophic-lateral-sclerosis-treatment-embracing-alternative-model-conceptualizations.pdf2023-11-27T18:51Znever https://www.amylyx.com/image/zoom-call-screenshot-with-all-members-showing-als-tattoos-for-inkedforals-02021-10-12T14:56Znever https://www.amylyx.com/image/amylyx-chief-medical-officer-camille-bedrosian2024-12-20T11:43Znever https://www.amylyx.com/document/a-joint-model-for-assessing-mortality-adjusted-progression-map-in-amyotrophic-lateral-sclerosis-application-to-clinical-trials-of-sodium-phenylbutyrate.pdf2023-12-08T18:15Znever https://www.amylyx.com/image/pipeline-graphic-162023-12-22T14:39Znever https://www.amylyx.com/image/pipeline-graphic-172023-12-22T14:39Znever https://www.amylyx.com/image/white-logo-of-orion2024-02-05T03:50Znever https://www.amylyx.com/image/system-of-neurons-with-glowing-connections-on-black-background2024-02-05T03:51Znever https://www.amylyx.com/image/a-system-of-neurons-with-glowing-connections2024-02-05T03:52Znever https://www.amylyx.com/image/icon-information2024-02-05T05:18Znever https://www.amylyx.com/image/amylyx-chief-human-resources-officer-linda-arsenault2025-01-06T07:26Znever https://www.amylyx.com/image/ceo-soak-josh-cohen-and-justin-klee-standing-in-water-fountain-wearing-suits2021-12-03T14:54Znever https://www.amylyx.com/relyvrio-us-connecticut-wac-disclosure.pdf2024-03-05T16:19Znever https://www.amylyx.com/document/next-steps-in-development-for-amx0114-an-antisense-oligonucleotide-targeting-calpain-2-a-critical-effector-of-axonal-degeneration.pdf2024-03-05T21:26Znever https://www.amylyx.com/document/findings-from-a-pharmacokinetic-and-pharmacodynamic-study-of-sodium-phenylbutyrate-and-taurursodiol-in-participants-with-amyotrophic-lateral-sclerosis.pdf2024-03-05T21:26Znever https://www.amylyx.com/document/orion-a-global-phase-3-randomized-double-blind-placebo-controlled-trial-of-amx0035-in-progressive-supranuclear-palsy.pdf2024-03-06T14:59Znever https://www.amylyx.com/document/relyvrio-enrollment-form.pdf2024-03-07T20:37Znever https://www.amylyx.com/image/relyvrio-logo-12024-03-08T12:06Znever https://www.amylyx.com/image/karen-firestone-headshot2024-03-11T17:27Znever https://www.amylyx.com/image/bernhardt-z-headshot2024-03-13T22:09Znever https://www.amylyx.com/image/progressive-supranuclear-palsy-information-from-amylyx2024-04-04T12:11Znever https://www.amylyx.com/image/psp-information-amylyx2024-04-16T14:17Znever https://www.amylyx.com/image/ceo-soak-josh-cohen-and-justin-klee-standing-in-water-fountain-wearing-suits-02021-12-03T14:54Znever https://www.amylyx.com/document/final-aan-oral-presentation.pdf2024-04-16T17:32Znever https://www.amylyx.com/image/amylyx-timeline-pathway-to-progress2024-04-23T19:45Znever https://www.amylyx.com/image/amylyx-timeline-pathway-to-progress-02024-04-23T19:45Znever https://www.amylyx.com/document/final-TIDES-AMX0114-poster.pdf2024-05-17T04:17Znever https://www.amylyx.com/document/final-CNSF-adherence-poster.pdf2024-05-22T04:10Znever https://www.amylyx.com/document/albrioza-product-monograph.pdf2024-06-07T04:23Znever https://www.amylyx.com/document/albrioza-product-monograph-fr.pdf2024-06-07T04:23Znever https://www.amylyx.com/document/health-product-risk-communication.pdf2024-06-07T04:21Znever https://www.amylyx.com/document/health-product-risk-communication-fr.pdf2024-06-07T04:22Znever https://www.amylyx.com/document/learnings-from-the-centaur-and-phoenix-trials-biomarker-results.pdf2024-06-19T04:23Znever https://www.amylyx.com/image/group-photo-of-amylyx-team-smiling-outdoors-standing-together-02021-10-14T05:17Znever https://www.amylyx.com/document/results-from-the-global-phase-3-trial-evaluating-sodium-phenylbutyrate-and-ursodoxicoltaurine-in-als.pdf2024-06-19T04:24Znever https://www.amylyx.com/document/updates-on-development-of-amx0114-an-antisense-oligonucleotide-inhibitor-of-calpain-2-a-critical-effector-of-axonal-degeneration.pdf2024-06-19T04:25Znever https://www.amylyx.com/image/3d-rendering-of-a-blue-glp-1-receptor-spanning-a-cell-membrane-three-g-proteins-float-below-the-receptor-inside-the-cell2024-12-20T12:21Znever https://www.amylyx.com/document/avexitide-ENDO-2022-presentation.pdf2024-07-15T04:51Znever https://www.amylyx.com/document/Oligos-for-CNS-AMX0114-presentation.pdf2024-07-15T04:58Znever https://www.amylyx.com/document/MDS-ORION.pdf2024-10-02T05:45Znever https://www.amylyx.com/document/ISPAD-HELIOS.pdf2024-10-17T17:33Znever https://www.amylyx.com/document/NEALS-LUMINA.pdf2024-10-24T04:46Znever https://www.amylyx.com/document/International-Wolfram-Symposium-HELIOS.pdf2024-10-25T04:40Znever https://www.amylyx.com/ALS-One-AMX01142024-11-15T05:30Znever https://www.amylyx.com/image/als-patient-in-motorized-chair-with-family-member-and-dog-02021-10-14T06:46Znever https://www.amylyx.com/CNS-HELIOS2024-11-15T05:32Znever https://www.amylyx.com/remote-videos/amylyx-living-with-wolfram-syndrome2024-11-27T13:31Znever https://www.amylyx.com/image/thumbnail-that-links-to-a-video-on-vimeo-of-raquel-a-young-woman-sharing-her-experience-living-with-wolfram-syndrome2024-12-20T12:23Znever https://www.amylyx.com/image/icon-plus2024-11-28T10:11Znever https://www.amylyx.com/remote-videos/slowmo-hug-zoom102024-11-29T13:29Znever https://www.amylyx.com/image/employees-engaging-in-a-group-session-at-amylyx-company-wide-meeting-02024-12-20T11:32Znever https://www.amylyx.com/image/employees-posing-at-amylyx-office-with-guests-from-the-community2024-12-20T11:18Znever https://www.amylyx.com/image/computer-generated-image-of-purple-and-blue-neurons-that-are-illuminated-by-twisting-neon-pink-strands-that-form-a-path-of-light2024-12-20T11:18Znever https://www.amylyx.com/image/amylyx-employees-at-a-boston-als-walk2024-12-20T12:28Znever https://www.amylyx.com/image/group-photo-of-amylyx-team-smiling-outdoors-standing-together-12021-10-14T07:19Znever https://www.amylyx.com/image/representation-of-amylyx-collaboration-with-the-community-purple-and-teal-concentric-rings-surround-a-lavender-circle2024-12-20T12:28Znever https://www.amylyx.com/image/representation-of-amylyx-ripple-effect-of-collaboration-the-center-of-the-circle-reads-rooted-in-connection2024-12-20T12:28Znever https://www.amylyx.com/image/amylyx-leadership-team-smiling-in-front-of-the-amylyx-sign-the-sign-reads-rooted-in-connection2025-09-25T04:35Zyearly https://www.amylyx.com/image/venn-diagram-of-amylyx-rd-strategy-mechanism-of-action-and-mechanism-of-disease-overlap-as-area-for-amylyx-impact2024-12-11T07:30Znever https://www.amylyx.com/image/the-full-amylyx-team-posing-together-in-their-cafeteria-arranged-in-five-long-rows2024-12-23T06:36Znever https://www.amylyx.com/image/microscopic-view-of-tau-protein-colored-turquoise-blue-to-contrast-against-a-navy-blue-backdrop2024-12-10T06:20Znever https://www.amylyx.com/image/four-amylyx-employees-preparing-care-packages-consisting-of-water-and-healthy-snacks-for-kids-attending-grade-school-in-the-greater-boston-area2024-12-10T06:20Znever https://www.amylyx.com/image/amylyx-employee-junliang-chen2024-12-10T06:21Znever https://www.amylyx.com/image/man-smiling-in-the-foreground-with-a-notecard-on-his-forehead-with-other-participants-in-the-activity-in-the-background2023-05-05T10:12Znever https://www.amylyx.com/image/amylyx-employee-izzy-shaw2024-12-30T02:55Znever https://www.amylyx.com/image/amylyx-employee-edgar-ramos2024-12-30T02:55Znever https://www.amylyx.com/image/company-mission2024-12-04T11:22Znever https://www.amylyx.com/image/microscopic-view-of-tau-protein-colored-turquoise-blue-to-contrast-against-a-navy-blue-backdrop-02024-12-30T02:45Znever https://www.amylyx.com/image/amylyx-chief-medical-officer-camille-bedrosian-speaking-on-a-panel-about-innovation-in-neurodengerative-diseases-at-an-industry-event2024-12-20T08:06Znever https://www.amylyx.com/image/co-founders-justin-klee-and-josh-cohen-in-the-early-days-of-amylyx-posing-together-behind-a-table-of-research-02025-01-06T05:26Znever https://www.amylyx.com/image/amylyx-co-ceos-josh-cohen-and-justin-klee-addressing-a-crowd-at-an-als-community-walk2025-01-06T07:42Znever https://www.amylyx.com/image/amylyx-employees-holding-up-their-company-t-shirts-at-an-als-walk-the-shirt-reads-taking-steps-to-end-als2024-12-20T07:58Znever https://www.amylyx.com/image/amylyx-co-ceos-justin-klee-and-josh-cohen-posing-together-in-labcoats2024-12-20T07:58Znever https://www.amylyx.com/image/microscopic-view-of-neurons-colored-bright-green-to-contrast-against-a-navy-blue-backdrop2024-12-20T12:25Znever https://www.amylyx.com/image/patientcaregiver2021-10-14T10:19Znever https://www.amylyx.com/image/person-living-with-als-being-helped-by-caregiver-out-of-electric-wheelchair2024-12-20T12:26Znever https://www.amylyx.com/document/WCIRDC-avexitide.pdf2024-12-10T04:44Znever https://www.amylyx.com/image/employees-engaging-in-a-group-session-at-amylyx-company-wide-meeting2024-12-10T09:57Znever https://www.amylyx.com/image/chart-demonstrating-that-amx0114-reduces-extracellular-neurofilament-light-chain-levels-in-multiple-models2024-12-30T03:04Znever https://www.amylyx.com/image/amylyx-employees-at-ceo-soak-ice-bucket-challenge2024-12-20T12:31Znever https://www.amylyx.com/image/close-up-view-of-a-western-blot-lab-test-ten-green-ovals-form-a-line-at-the-bottom-the-notations-read-130-and-1002024-12-11T11:44Znever https://www.amylyx.com/image/logo-for-amylyx-clinical-trial-named-lucidity2024-12-12T04:49Znever https://www.amylyx.com/image/logo-for-amylyx-clinical-trial-named-helios2024-12-12T04:50Znever https://www.amylyx.com/image/logo-for-amylyx-clinical-trial-named-orion2024-12-20T12:00Znever https://www.amylyx.com/image/logo-for-amylyx-clinical-trial-named-lumina2024-12-20T12:01Znever https://www.amylyx.com/image/light-micrograph-of-branch-like-nerve-cells-in-the-cerebellum-filled-with-fluorescent-green-dye-against-a-blue-background2024-12-17T01:47Znever https://www.amylyx.com/image/microscopic-view-of-tau-protein-colored-a-blue-gray-to-contrast-against-a-navy-blue-backdrop2024-12-17T01:50Znever https://www.amylyx.com/image/table-of-results-from-a-nature-published-analysis-implicating-glial-activation-and-novel-risk-genes-in-progressive-supranuclear-palsy2024-12-17T01:55Znever https://www.amylyx.com/image/chart-demonstrating-amx0035-significantly-lowered-csf-tau-and-p-tau-in-the-pegasus-alzheimers-disease-trial2024-12-17T01:56Znever https://www.amylyx.com/image/logo-for-amylyx-clinical-trial-named-lucidity-02024-12-30T02:57Znever https://www.amylyx.com/image/logo-for-amylyx-clinical-trial-named-helios-02024-12-20T12:00Znever https://www.amylyx.com/image/chart-demonstrating-that-avexitide-reduced-daily-rates-of-hypoglycemia-by-greater-than-50-in-2-phase-2-pbh-clinical-trials2024-12-23T10:07Znever https://www.amylyx.com/image/light-micrograph-of-stomach-surface-epithelium-the-bright-green-mucous-cells-contrast-against-the-blue-background2024-12-23T10:08Znever https://www.amylyx.com/image/light-micrograph-of-a-retinal-ganglion-in-which-bright-green-cell-bodies-contrast-against-a-navy-blue-background2024-12-30T08:08Znever https://www.amylyx.com/image/chart-showing-increased-mean-c-peptide-production-at-120-minutes-in-response-to-the-mixed-meal-tolerance-test-in-helios2024-12-30T08:10Znever https://www.amylyx.com/image/3d-pie-chart-showing-the-prevalence-of-pbh-using-concentric-gray-teal-and-orange-circles2024-12-23T10:08Znever https://www.amylyx.com/image/amylyx-co-ceos-josh-cohen-and-justin-klee-at-an-als-community-walk2024-12-23T06:13Znever https://www.amylyx.com/remote-videos/amylyx-living-with-wolfram-syndrome-02024-12-24T09:20Znever https://www.amylyx.com/image/amylyx-chief-commercial-officer-dan-monahan2025-09-25T04:34Zyearly https://www.amylyx.com/image/microscopic-view-of-tau-protein-colored-a-blue-gray-to-contrast-against-a-navy-blue-backdrop-02025-01-06T06:46Znever https://www.amylyx.com/image/chart-demonstrating-that-avexitide-reduced-daily-rates-of-hypoglycemia-by-greater-than-50-in-2-phase-2-pbh-clinical-trials-02025-01-08T03:46Znever https://www.amylyx.com/image/amylyx-chief-medical-officer-camille-bedrosian-02025-01-06T07:23Znever https://www.amylyx.com/image/amylyx-co-founder-and-co-ceo-justin-klee-02025-01-06T07:35Znever https://www.amylyx.com/image/amylyx-co-founder-and-co-ceo-josh-cohen-02025-01-08T04:19Znever https://www.amylyx.com/image/amylyx-chief-legal-office-gina-mazzariello-02025-01-06T07:49Znever https://www.amylyx.com/image/white-logo-of-phoenix2021-12-02T10:42Znever https://www.amylyx.com/image/3d-pie-chart-showing-the-prevalence-of-pbh-using-concentric-gray-teal-and-orange-circles-02025-01-14T06:47Znever https://www.amylyx.com/image/chart-demonstrating-that-avexitide-reduced-daily-rates-of-hypoglycemia-by-greater-than-50-in-2-phase-2-pbh-clinical-trials-12025-01-14T06:47Znever https://www.amylyx.com/image/chart-showing-increased-mean-c-peptide-production-at-120-minutes-in-response-to-the-mixed-meal-tolerance-test-in-helios-02025-01-14T06:47Znever https://www.amylyx.com/image/chart-demonstrating-that-avexitide-reduced-daily-rates-of-hypoglycemia-by-greater-than-50-in-2-phase-2-pbh-clinical-trials-22025-01-14T06:48Znever https://www.amylyx.com/image/chart-demonstrating-that-amx0114-reduces-extracellular-neurofilament-light-chain-levels-in-multiple-models-02025-01-14T06:48Znever https://www.amylyx.com/document/amylyx-supplier-code-of-conduct.pdf2025-10-29T04:19Zyearly https://www.amylyx.com/image/the-amylyx-team-posing-in-the-cambridge-office2025-04-17T03:21Zyearly https://www.amylyx.com/image/graphic-depicting-the-educational-pbh-guide-available-for-download-as-a-pdf2025-04-17T03:22Zyearly https://www.amylyx.com/image/graphic-displaying-key-milestones-in-the-amx0035-pipeline2021-12-02T11:02Znever https://www.amylyx.com/document/educational-PBH-guide-digital.pdf2025-04-17T13:40Zyearly https://www.amylyx.com/document/educational-PBH-guide-print.pdf2025-04-17T13:40Zyearly https://www.amylyx.com/image/maggie-a-woman-living-with-pbh-smiling-in-a-park2025-04-17T03:25Zyearly https://www.amylyx.com/image/thumbnail-that-links-to-a-video-on-vimeo-of-raquel-a-young-woman-sharing-her-experience-living-with-wolfram-syndrome-02025-04-17T03:25Zyearly https://www.amylyx.com/image/light-micrograph-of-pancreatic-beta-cells-the-bright-green-cells-contrast-against-the-blue-background2025-04-17T03:26Zyearly https://www.amylyx.com/image/funnel-graphic-depicting-the-prevalence-of-pbh-in-the-united-states-160000-people-are-currently-living-with-the-condition2025-08-28T05:03Zyearly https://www.amylyx.com/remote-videos/amylyx-spotlight-on-living-with-post-bariatric-hypoglycemia-pbh2025-04-17T03:26Zyearly https://www.amylyx.com/image/amylyx-employee-alberto-sepulveda2025-10-28T05:32Zyearly https://www.amylyx.com/document/48-week-HELIOSTrialA.pdf2025-05-12T11:57Zyearly https://www.amylyx.com/image/amylyx-employee-katrina-carey2025-06-03T09:24Zyearly https://www.amylyx.com/image/graphic-displaying-key-milestones-in-the-amx0035-pipeline-02021-12-02T11:01Znever https://www.amylyx.com/image/amylyx-employee-joe-wong2025-06-03T09:28Zyearly https://www.amylyx.com/image/amylyx-employee-kelly-sorel2025-06-03T10:22Zyearly https://www.amylyx.com/document/ENCALS-AMX0035.pdf2025-06-06T05:09Zyearly https://www.amylyx.com/document/CNSF-AMX0114.pdf2025-06-13T06:02Zyearly https://www.amylyx.com/document/ENDO-avexitide-PKPD-poster.pdf2025-07-15T05:17Zyearly https://www.amylyx.com/document/ENDO-avexitide-results-poster.pdf2025-07-15T05:18Zyearly https://www.amylyx.com/document/ENDO-avexitide-results-presentation.pdf2025-07-15T05:19Zyearly https://www.amylyx.com/image/thumbnail-of-pdf-titled-understanding-pbh-a-community-guide-to-education-and-support2025-07-23T04:47Zyearly https://www.amylyx.com/image/woman-posing-with-a-look-of-determination2025-07-23T04:48Zyearly https://www.amylyx.com/image/woman-sitting-in-a-kayak-on-a-nice-day-on-a-lake2025-07-23T05:43Zyearly https://www.amylyx.com/image/neuron-image2021-10-27T08:34Znever https://www.amylyx.com/image/woman-sitting-in-a-kayak-on-a-nice-day-on-a-lake-02025-07-23T05:45Zyearly https://www.amylyx.com/image/side-by-side-photos-of-a-woman-that-show-her-weight-loss-after-bariatric-surgery2025-07-23T05:46Zyearly https://www.amylyx.com/image/a-newly-married-couple-smiling-at-each-other-a-rainbow-visible-behind-them2025-07-23T05:47Zyearly https://www.amylyx.com/image/two-parents-helping-their-son-blow-out-a-birthday-candle2025-07-23T05:48Zyearly https://www.amylyx.com/image/woman-posing-with-a-stroller-under-a-special-olympics-arch2025-07-23T05:49Zyearly https://www.amylyx.com/image/two-parents-holding-their-toddler-age-son-in-between-them2025-07-23T05:51Zyearly https://www.amylyx.com/image/woman-posing-with-a-look-of-determination-02025-07-23T05:52Zyearly https://www.amylyx.com/document/NEALS-LUMINA-presentation.pdf2025-10-07T04:27Zyearly https://www.amylyx.com/document/NEALS-calpain-2.pdf2025-10-07T04:28Zyearly https://www.amylyx.com/image/usa-flag2021-10-27T08:57Znever https://www.amylyx.com/document/NEALS-calpain-2-poster.pdf2025-10-07T04:28Zyearly https://www.amylyx.com/document/MDS-ORION-presentation.pdf2025-10-08T04:12Zyearly https://www.amylyx.com/remote-videos/amylyx-spotlight-on-living-with-post-bariatric-hypoglycemia-pbh-02025-10-09T04:34Zyearly https://www.amylyx.com/image/maria-and-her-daughter-kelly-embracing2025-10-09T04:35Zyearly https://www.amylyx.com/image/amylyx-employee-tapan-desai2025-10-29T04:18Zyearly https://www.amylyx.com/image/amylyx-employee-natalia-vlcek2025-10-29T04:18Zyearly https://www.amylyx.com/image/amylyx-employee-dan-monahan2025-10-29T04:19Zyearly https://www.amylyx.com/document/Virtual-Trial-Update-48-week-HELIOS-Trial.pdf2025-11-21T04:30Zyearly https://www.amylyx.com/document/terms-and-conditions-for-the-purchase-of-services.pdf2025-11-25T04:16Zyearly https://www.amylyx.com/document/MNDA-2025-Calpain.pdf2025-12-08T04:13Zyearly https://www.amylyx.com/image/canada-flag2021-10-27T08:58Znever https://www.amylyx.com/document/MNDA-2025-LUMINA.pdf2025-12-08T04:14Zyearly https://www.amylyx.com/document/MDA-2026-LUMINA.pdf2026-03-11T14:36Zyearly https://www.amylyx.com/image/netherlands-flag2021-10-27T08:58Znever https://www.amylyx.com/image/als-patient-standing-with-family-member-pointing-at-camera2021-10-05T11:21Znever https://www.amylyx.com/image/company-banner-image2021-10-27T16:45Znever https://www.amylyx.com/image/logo-for-the-als-association2021-12-02T11:12Znever https://www.amylyx.com/image/als-netherlands-logo2021-10-27T16:54Znever https://www.amylyx.com/image/logo-for-alzheimers-association2021-12-02T11:22Znever https://www.amylyx.com/image/alzheimers-drug-discovery-foundation-logo2021-10-28T05:32Znever https://www.amylyx.com/image/logo-for-als-society-of-canada2021-12-02T11:15Znever https://www.amylyx.com/image/logo-for-i-am-als2021-12-02T11:18Znever https://www.amylyx.com/image/logo-for-neals2021-12-02T11:20Znever https://www.amylyx.com/image/amylyx-logo2021-10-28T05:35Znever https://www.amylyx.com/image/logo-for-project-als2021-12-02T11:21Znever https://www.amylyx.com/image/zoomed-in-photo-of-human-cell2021-11-12T03:55Znever https://www.amylyx.com/image/logo-for-les-turner-als-foundation2021-12-02T11:19Znever https://www.amylyx.com/image/logo-for-cure-alzheimers-fund2021-12-02T11:23Znever https://www.amylyx.com/image/logo-for-muscular-dystrophy-association2021-12-02T11:20Znever https://www.amylyx.com/image/logo-for-compassionate-care-als2021-12-02T11:17Znever https://www.amylyx.com/image/logo-for-als-finding-a-cure2021-12-02T11:12Znever https://www.amylyx.com/image/logo-for-eupals2021-12-02T11:17Znever https://www.amylyx.com/image/international-alliance-of-als/mnd-association-logo2021-10-28T05:39Znever https://www.amylyx.com/image/als-sla-action-canada-logo2021-10-28T05:41Znever https://www.amylyx.com/image/media-banner-image2021-10-28T12:11Znever https://www.amylyx.com/image/our-values-background-image2021-10-29T04:44Znever https://www.amylyx.com/image/picture-of-woman-walking-with-support-sticks2021-10-05T11:22Znever https://www.amylyx.com/image/twitter-profile-image2021-10-29T04:52Znever https://www.amylyx.com/image/media-hero-banner2021-10-29T08:04Znever https://www.amylyx.com/image/our-mission-video-thumbnail2021-11-01T05:39Znever https://www.amylyx.com/image/our-values-image2021-11-01T07:31Znever https://www.amylyx.com/image/audacious-icon2021-11-01T09:13Znever https://www.amylyx.com/image/curious-icon2021-11-01T09:14Znever https://www.amylyx.com/image/engaged-icon2021-11-01T09:15Znever https://www.amylyx.com/image/accountable-icon2021-11-01T09:15Znever https://www.amylyx.com/image/authentic-icon2021-11-01T09:16Znever https://www.amylyx.com/image/icon-of-two-people-shaking-hands-to-demonstrate-amylyx-core-value-of-be-accountable2024-12-10T06:19Znever https://www.amylyx.com/image/headshot-of-als-wife-and-caregiver2021-10-05T11:24Znever https://www.amylyx.com/image/group-photo-of-amylyx-team-members-standing-at-the-red-sox-stadium2021-12-06T06:19Znever https://www.amylyx.com/image/picture-of-josh-cohen-justin-klee-standing2021-12-06T06:20Znever https://www.amylyx.com/image/our-company-hero-banner2021-11-03T04:42Znever https://www.amylyx.com/image/curious-icon-02021-12-06T06:23Znever https://www.amylyx.com/image/group-photo-of-amylyx-team-smiling-outdoors-standing-together-22021-11-12T04:07Znever https://www.amylyx.com/image/group-photo-of-amylyx-team-smiling-outdoors-standing-together-32021-11-12T04:07Znever https://www.amylyx.com/image/group-photo-of-amylyx-team-smiling-outdoors-standing-together-42021-12-02T10:40Znever https://www.amylyx.com/image/group-photo-of-amylyx-team-smiling-outdoors-standing-together-52021-12-02T10:40Znever https://www.amylyx.com/image/group-photo-of-amylyx-employees-wearing-medical-masks-outdoors2021-10-06T06:11Znever https://www.amylyx.com/image/zoomed-in-microscopic-view-of-motor-neuron2021-12-02T10:16Znever https://www.amylyx.com/image/headshot-of-josh-cohen2021-12-02T11:29Znever https://www.amylyx.com/image/headshot-of-debra-canner2021-12-02T11:29Znever https://www.amylyx.com/image/headshot-of-james-m-frates2021-12-02T11:30Znever https://www.amylyx.com/image/headshot-of-tom-holmes2021-12-02T11:30Znever https://www.amylyx.com/image/headshot-of-justin-klee2021-12-02T11:30Znever https://www.amylyx.com/image/headshot-of-margaret-olinger2021-12-02T11:31Znever https://www.amylyx.com/image/headshot-of-patrick-yeramian2021-12-02T11:32Znever https://www.amylyx.com/image/headshot-of-rudolph-tanzi2021-12-02T11:32Znever https://www.amylyx.com/image/headshot-of-wally-gilbert2021-12-02T11:32Znever https://www.amylyx.com/image/als-patient-and-smiling-child-hugging-with-closed-eyes2021-10-07T05:46Znever https://www.amylyx.com/image/white-logo-of-centaur-02021-12-02T10:53Znever https://www.amylyx.com/remote-videos/results-from-the-centaur-trial2021-11-17T07:32Znever https://www.amylyx.com/image/headshot-of-felix-von-coerper2021-12-02T11:35Znever https://www.amylyx.com/image/headshot-of-paul-fonteyne2021-12-02T11:36Znever https://www.amylyx.com/image/headshot-of-george-milne2021-12-02T11:36Znever https://www.amylyx.com/image/headshot-of-daphne-quimi2021-12-02T11:37Znever https://www.amylyx.com/image/headshot-of-alan-walts2021-12-02T11:37Znever https://www.amylyx.com/image/headshot-of-henri-termeer2021-12-02T11:38Znever https://www.amylyx.com/image/centaur-video-thumbnail2021-11-18T09:04Znever https://www.amylyx.com/image/als-patient-and-smiling-child-hugging-with-closed-eyes-02021-10-07T05:46Znever https://www.amylyx.com/image/graph-displaying-the-als-functional-rating-scale-alsfrs-r-total-at-week-24-in-the-centaur-trial2021-12-02T10:49Znever https://www.amylyx.com/remote-videos/results-from-the-centaur-trial-02021-11-18T12:00Znever https://www.amylyx.com/image/map-of-the-united-states-displaying-locations-of-the-centaur-trial2021-12-02T10:50Znever https://www.amylyx.com/image/zoomed-in-microscopic-view-of-motor-neuron-02021-12-02T10:44Znever https://www.amylyx.com/image/our-path-to-progress-image2021-11-19T03:51Znever https://www.amylyx.com/image/our-path-to-progress-image-02021-11-19T03:52Znever https://www.amylyx.com/image/person-living-with-als-holding-a-plate-and-a-man-standing-both-next-to-grill-and-smiling2021-12-02T10:48Znever https://www.amylyx.com/image/logo-for-als-liga-belgium2021-12-02T11:13Znever https://www.amylyx.com/image/group-photo-of-amylyx-team-smiling-outdoors-standing-together2021-10-05T08:43Znever https://www.amylyx.com/image/logo-for-als-one2021-12-02T11:14Znever https://www.amylyx.com/image/logo-for-als-stichting2021-12-02T11:16Znever https://www.amylyx.com/image/als-patient-and-smiling-child-hugging-with-closed-eyes-12021-10-07T05:47Znever https://www.amylyx.com/image/logo-for-als-therapy-development-institute2021-12-02T11:16Znever https://www.amylyx.com/image/logo-for-international-alliance-of-als/mnd-associations2021-12-02T11:19Znever https://www.amylyx.com/image/logo-for-alzheimers-drug-discovery-foundation2021-12-02T11:22Znever https://www.amylyx.com/image/zoomed-in-microscopic-view-of-neuron-blue2021-12-02T11:26Znever https://www.amylyx.com/image/person-living-with-als-holding-a-plate-and-a-man-standing-both-next-to-grill-and-smiling-02021-12-02T10:48Znever https://www.amylyx.com/image/graphic-displaying-the-combination-of-pb-and-turso-and-its-impact-on-cortical-neuronal-viability2021-12-02T10:52Znever https://www.amylyx.com/image/two-people-smiling-and-pointing-at-camera2021-12-02T10:45Znever https://www.amylyx.com/image/person-living-with-als-in-a-motorized-chair-and-their-caregiver-smiling2021-12-02T10:43Znever https://www.amylyx.com/image/smiling-als-patient-in-motorized-chair-next-to-smiling-caregiver2021-10-07T05:52Znever https://www.amylyx.com/remote-videos/amylyx-commitment-to-patients2021-11-24T05:30Znever https://www.amylyx.com/image/zoomed-in-microscopic-view-of-mitochondria2021-12-02T11:07Znever https://www.amylyx.com/image/zoomed-in-microscopic-view-of-motor-neuron-12021-12-06T09:43Znever https://www.amylyx.com/image/zoomed-in-microscopic-view-of-motor-neuron-22021-12-06T09:43Znever https://www.amylyx.com/remote-videos/als-mod2021-11-25T06:48Znever https://www.amylyx.com/image/mechanism-of-disease2021-11-26T13:02Znever https://www.amylyx.com/image/group-photo-of-amylyx-team-smiling-outdoors-standing-together-62021-11-25T12:40Znever https://www.amylyx.com/image/amylyx-employees-completing-an-als-walk-together2021-12-02T10:25Znever https://www.amylyx.com/image/amylyx-employees-holding-up-their-team-shirts-at-an-als-walk2021-11-25T12:55Znever https://www.amylyx.com/image/smiling-als-patient-in-motorized-chair-next-to-smiling-caregiver-02021-10-07T05:53Znever https://www.amylyx.com/image/amylyx-employees-completing-an-als-walk-together-02021-11-25T13:09Znever https://www.amylyx.com/image/graphic-displaying-key-milestones-in-the-amx0035-pipeline-12021-12-02T10:56Znever https://www.amylyx.com/image/graphic-displaying-key-milestones-in-the-amx0035-pipeline-22021-12-02T10:55Znever https://www.amylyx.com/image/group-photo-of-amylyx-team-smiling-outdoors-standing-together-72021-11-26T04:29Znever https://www.amylyx.com/image/group-photo-of-amylyx-team-smiling-outdoors-standing-together-82021-11-26T04:34Znever https://www.amylyx.com/image/members-of-the-amylyx-team-complete-an-als-walk-together2021-11-26T04:42Znever https://www.amylyx.com/image/smiling-als-patient-in-motorized-chair-next-to-smiling-caregiver-12021-10-07T05:53Znever https://www.amylyx.com/remote-videos/amylyx-commitment-to-patients-02021-11-26T05:04Znever https://www.amylyx.com/remote-videos/amylyx-commitment-to-patients-12021-11-26T06:04Znever https://www.amylyx.com/remote-videos/results-from-the-centaur-trial-12021-11-26T06:06Znever https://www.amylyx.com/remote-videos/amylyx-commitment-to-patients-22021-11-26T06:15Znever https://www.amylyx.com/image/group-photo-of-amylyx-team-members-standing-at-the-red-sox-stadium-02021-12-06T06:19Znever https://www.amylyx.com/image/mechanism-of-disease-02021-11-26T14:55Znever https://www.amylyx.com/image/zoomed-in-microscopic-view-of-mitochondria-02021-12-02T11:07Znever https://www.amylyx.com/image/members-of-the-amylyx-team-complete-an-als-walk-together-02021-11-29T10:03Znever https://www.amylyx.com/image/laughing-als-patient-in-motorized-chair-next-to-smiling-caregiver2021-10-07T05:54Znever https://www.amylyx.com/image/als-patient-in-motorized-chair-with-family-member-and-dog-12021-12-02T05:49Znever https://www.amylyx.com/image/amx0035-pipeline-upcoming-milestones-02021-12-02T06:25Znever https://www.amylyx.com/image/amx0035-pipeline-upcoming-milestones-12021-12-02T06:26Znever https://www.amylyx.com/image/amylyx-employees-holding-up-their-team-shirts-at-an-als-walk-02021-12-02T07:02Znever https://www.amylyx.com/image/amylyx-employees-completing-an-als-walk-together-12021-12-02T10:26Znever https://www.amylyx.com/image/laughing-als-patient-in-motorized-chair-next-to-smiling-caregiver-02021-10-07T05:54Znever https://www.amylyx.com/image/members-of-the-amylyx-team-complete-an-als-walk-together-12021-12-02T10:31Znever https://www.amylyx.com/image/group-photo-of-amylyx-team-smiling-outdoors-standing-together-92021-12-02T09:29Znever https://www.amylyx.com/image/picture-of-josh-cohen-justin-klee-standing-02021-12-06T06:21Znever https://www.amylyx.com/image/als-patient-in-motorized-chair-with-family-member-and-dog-22021-12-02T12:50Znever https://www.amylyx.com/image/zoomed-in-microscopic-view-of-mitochondria-showing-early-stage-neuron-death2021-12-06T09:44Znever https://www.amylyx.com/image/zoomed-in-microscopic-view-of-mitochondria-showing-late-stage-neuron-death2021-12-06T09:45Znever https://www.amylyx.com/image/headshot-of-person-living-with-als2021-12-03T12:10Znever https://www.amylyx.com/image/headshot-of-person-living-with-als-02021-12-03T12:15Znever https://www.amylyx.com/image/headshot-of-person-living-with-als-12021-12-03T12:19Znever https://www.amylyx.com/image/laughing-als-patient-in-motorized-chair-next-to-smiling-caregiver-12021-10-07T05:55Znever https://www.amylyx.com/image/amylyx-employees-on-stairs-wearing-medical-masks2021-12-03T14:46Znever https://www.amylyx.com/image/picture-of-josh-cohen-justin-klee-standing-12021-12-06T13:29Znever https://www.amylyx.com/image/zoomed-in-microscopic-view-of-motor-neuron-32021-12-07T12:09Znever https://www.amylyx.com/image/headshot-of-person-living-with-als-22021-12-07T14:37Znever https://www.amylyx.com/image/headshot-of-josh-cohen-02024-12-02T17:21Znever https://www.amylyx.com/image/headshot-of-justin-klee-02021-12-09T05:32Znever https://www.amylyx.com/image/headshot-of-margaret-olinger-02021-12-09T05:42Znever https://www.amylyx.com/image/amylyx-employees-wearing-masks-standing-on-stairs-outdoors2021-10-07T05:59Znever https://www.amylyx.com/image/headshot-of-rudolph-tanzi-02021-12-09T06:14Znever https://www.amylyx.com/image/headshot-of-wally-gilbert-02021-12-09T06:27Znever https://www.amylyx.com/image/headshot-of-felix-von-coerper-02021-12-09T06:57Znever https://www.amylyx.com/image/headshot-of-george-milne-02021-12-09T06:58Znever https://www.amylyx.com/image/headshot-of-alan-walts-02021-12-09T06:58Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-exclusive-amx0035-distribution-agreement-with-israel-based-neopharm2023-04-03T05:23Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-completion-of-enrollment-in-global-phase-3-phoenix-trial-of-amx0035-in-als2023-04-03T05:23Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-to-participate-in-the-svb-securities-global-biopharma-conference2023-04-03T05:22Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-to-report-fourth-quarter-and-full-year-2022-financial-results-on-march-13-20232023-04-03T05:22Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-to-participate-in-upcoming-investor-conferences2023-04-03T05:22Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-reports-fourth-quarter-and-full-year-2022-financial-results2023-04-03T05:22Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-to-present-at-the-22nd-annual-needham-virtual-healthcare-conference2023-04-11T13:01Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-first-participant-dosed-in-phase-2-study-of-amx0035-for-the-treatment-of-wolfram-syndrome2023-04-13T13:01Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-appoints-masako-nakamura-to-general-manager-and-head-of-international-markets-asia-pacific-and-latin-america2023-04-20T13:03Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-to-report-first-quarter-2023-financial-results-on-may-11-20232023-05-05T13:04Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-reports-first-quarter-2023-financial-results2023-05-11T20:10Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-provides-update-on-ongoing-regulatory-review-of-amx0035-for-the-treatment-of-als-in-the-european-union2023-05-30T12:00Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-to-present-at-the-goldman-sachs-44th-annual-global-healthcare-conference2023-06-06T13:00Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-completes-negotiation-process-and-signs-letter-of-intent-with-the-pcpa-for-albriozatm-for-the-treatment-of-als2023-06-15T13:00Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-receives-chmp-negative-opinion-on-its-conditional-marketing-authorisation-application-for-amx0035-for-the-treatment-of-als-in-the-european-union2023-06-23T12:14Znever https://www.amylyx.com/news/ontario-to-publicly-reimburse-albriozatm-for-the-treatment-of-als2023-06-28T17:50Znever https://www.amylyx.com/news/government-of-quebec-to-cover-albriozatm-for-the-treatment-of-als2023-07-06T17:51Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-to-host-virtual-webcast-on-amx0035-progressive-supranuclear-palsy-psp-program2023-07-12T13:00Znever https://www.amylyx.com/news/british-columbia-to-publicly-reimburse-albriozatm-for-the-treatment-of-als2023-07-19T17:56Znever https://www.amylyx.com/als2026-03-24T11:04Zdaily https://www.amylyx.com/news/new-brunswick-to-publicly-reimburse-albriozatm-for-the-treatment-of-als2023-07-24T22:35Znever https://www.amylyx.com/news/alberta-to-provide-coverage-for-albriozatm-for-the-treatment-of-als2023-08-02T00:38Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-to-report-second-quarter-2023-financial-results-on-august-10-20232023-08-03T20:11Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-reports-second-quarter-2023-financial-results2023-08-10T20:02Znever https://www.amylyx.com/news/nova-scotia-to-provide-coverage-for-albriozatm-for-the-treatment-of-als2023-08-15T13:51Znever https://www.amylyx.com/news/newfoundland-and-labrador-to-provide-coverage-for-albriozatm-for-the-treatment-of-als2023-09-25T20:07Znever https://www.amylyx.com/news/government-of-manitoba-to-publicly-reimburse-albriozatm-for-the-treatment-of-als2023-09-25T20:07Znever https://www.amylyx.com/news/saskatchewan-to-provide-coverage-for-albriozatm-for-the-treatment-of-als2023-09-25T20:07Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-to-participate-in-upcoming-investor-conferences-02023-09-05T13:00Znever https://www.amylyx.com/news/relyvrior-and-amx0114-data-to-be-presented-at-22nd-annual-northeast-als-consortium-neals-meeting2023-10-02T13:01Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-provides-update-on-acces-compassionnel-for-amx0035-in-france2023-10-06T16:57Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-publication-of-survival-analysis-comparing-centaur-to-historical-clinical-trial-control2023-10-10T13:12Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-receives-negative-chmp-opinion-on-its-marketing-authorisation-application-for-amx0035-for-the-treatment-of-als-in-the-european-union-following-re-examination-process2023-10-13T12:33Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-to-present-clinical-trial-design-of-orion-a-phase-3-global-study-of-amx0035-in-progressive-supranuclear-palsy-psp-at-the-neuro2023-psp-and-cbd-international-research-symposium2023-10-20T17:16Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-to-report-third-quarter-2023-financial-results-on-november-9-20232023-11-02T13:00Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-reports-third-quarter-2023-financial-results2023-11-14T10:00Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-to-participate-at-the-6th-annual-evercore-isi-healthconx-conference2023-11-21T14:01Znever https://www.amylyx.com/news/amylyx-a-company-dedicated-to-discovery-and-development-of-treatments-for-als-and-other-neurodegenerative-diseases-establishes-a-japanese-subsidiary2023-11-27T12:52Znever https://www.amylyx.com/news/relyvrior-and-amx0114-data-to-be-presented-at-34th-international-symposium-on-als/mnd2023-11-27T14:00Znever https://www.amylyx.com/news/prince-edward-island-to-publicly-reimburse-albriozatm-for-the-treatment-of-als2023-11-27T19:33Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-appoints-camille-l-bedrosian-md-as-chief-medical-officer2023-11-28T12:01Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-inducement-grants-under-nasdaq-listing-rule-5635c42023-11-29T22:20Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-publication-of-data-showing-the-effect-of-amx0035-on-plasma-neuroinflammatory-biomarkers-in-als2023-12-11T07:56Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-first-participant-dosed-in-the-global-phase-3-orion-study-of-amx0035-in-progressive-supranuclear-palsy-psp2023-12-22T14:00Znever https://www.amylyx.com/our-company/leadership-team2026-02-04T04:17Zmonthly https://www.amylyx.com/wolfram-syndrome2026-01-08T12:02Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-completion-of-enrollment-in-helios-a-phase-2-study-of-amx0035-for-the-treatment-of-wolfram-syndrome2024-02-08T14:01Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-to-present-updates-on-its-amx0114-and-relyvrior-programs-in-als-at-the-2024-muscular-dystrophy-association-mda-clinical-and-scientific-conference2024-02-15T14:01Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-to-report-fourth-quarter-and-full-year-2023-financial-results-on-february-22-20242024-02-15T21:11Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-reports-fourth-quarter-and-full-year-2023-financial-results2024-02-22T13:54Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-inducement-grants-under-nasdaq-listing-rule-5635c4-02024-02-23T21:10Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-topline-results-from-global-phase-3-phoenix-trial-of-amx0035-in-als2024-03-08T12:00Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-appoints-bernhardt-zeiher-md-fccp-facp-to-its-board-of-directors2024-03-14T13:01Znever https://www.amylyx.com/hcp-privacy-notice2024-04-01T03:59Zyearly https://www.amylyx.com/cookie-notice2024-04-04T13:50Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-formal-intention-to-remove-relyvrior/albriozatm-from-the-market-provides-updates-on-access-to-therapy-pipeline-corporate-restructuring-and-strategy2024-04-04T11:10Zyearly https://www.amylyx.com/global-access-policy2024-12-23T04:39Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-to-host-virtual-webcast-to-discuss-interim-data-from-phase-2-helios-study-of-amx0035-in-wolfram-syndrome-on-april-10-20242024-04-08T13:02Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-interim-data-from-ongoing-phase-2-helios-clinical-trial-demonstrating-improvements-in-pancreatic-function-and-glycemic-control-with-amx0035-in-people-with-wolfram-syndrome2024-04-10T13:01Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-to-report-first-quarter-2024-financial-results-on-may-9-20242024-05-02T13:01Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-to-present-at-the-2024-bank-of-america-health-care-conference2024-05-08T13:00Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-reports-first-quarter-2024-financial-results2024-05-09T11:01Zyearly https://www.amylyx.com/consumer-health-data-privacy-notice2025-04-17T03:30Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-to-present-at-the-goldman-sachs-45th-annual-global-healthcare-conference2024-06-04T13:00Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-to-host-conference-call-to-discuss-the-acquisition-of-avexitide2024-07-09T20:01Zyearly https://www.amylyx.com/post-bariatric-hypoglycemia2026-03-24T11:04Zdaily https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-acquisition-of-phase-3-ready-glp-1-receptor-antagonist-avexitide-with-fda-breakthrough-therapy-designation2024-07-10T11:01Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-receives-orphan-drug-designation-from-the-european-commission-for-amx0035-for-the-treatment-of-wolfram-syndrome2024-08-02T13:01Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-to-report-second-quarter-2024-financial-results-on-august-8-20242024-08-05T13:01Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-reports-second-quarter-2024-financial-results2024-08-08T11:12Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-publication-of-data-showing-the-encouraging-effects-of-amx0035-on-cerebrospinal-fluid-biomarkers-of-core-alzheimers-disease-pathology-and-neurodegeneration2024-08-12T13:00Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-to-participate-in-upcoming-investor-conferences-12024-08-28T12:31Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-to-host-virtual-webcast-to-discuss-topline-results-from-phase-2-helios-study-of-amx0035-in-wolfram-syndrome-on-october-17-20242024-10-15T13:00Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-positive-topline-results-from-phase-2-helios-clinical-trial-demonstrating-sustained-improvements-with-amx0035-in-people-living-with-wolfram-syndrome2024-10-17T13:02Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-to-report-third-quarter-2024-financial-results-on-november-7-20242024-11-04T14:02Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-reports-third-quarter-2024-financial-results2024-11-07T12:02Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-appoints-dan-monahan-as-chief-commercial-officer2025-01-09T02:50Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-pivotal-phase-3-lucidity-trial-design-for-glp-1-receptor-antagonist-avexitide-in-post-bariatric-hypoglycemia2025-01-09T02:50Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-to-present-at-the-7th-annual-evercore-isi-healthconx-conference2025-01-09T02:50Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-proposed-public-offering-of-common-stock2025-01-10T00:31Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-pricing-of-public-offering-of-common-stock2025-01-10T13:27Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-fda-has-lifted-the-clinical-hold-on-amx0114-phase-1-clinical-trial-for-the-treatment-of-amyotrophic-lateral-sclerosis2025-01-21T14:00Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-to-present-at-the-oppenheimer-35th-annual-healthcare-life-sciences-conference2025-02-10T14:01Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-to-report-fourth-quarter-and-full-year-2024-financial-results-on-march-4-20252025-02-24T14:01Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-to-participate-in-upcoming-march-investor-conferences2025-02-25T14:01Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-reports-fourth-quarter-and-full-year-2024-financial-results2025-03-04T11:00Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-to-present-at-the-24th-annual-needham-virtual-healthcare-conference2025-04-02T13:00Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-first-participant-dosed-in-phase-1-multiple-ascending-dose-lumina-trial-of-amx0114-in-people-living-with-amyotrophic-lateral-sclerosis2025-04-09T11:01Zyearly https://www.amylyx.com/PBH-opt-in2026-01-22T02:47Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-first-participant-dosed-in-pivotal-phase-3-lucidity-trial-of-avexitide-in-post-bariatric-hypoglycemia2025-04-30T11:01Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-to-report-first-quarter-2025-financial-results-on-may-8-20252025-05-01T13:00Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-to-participate-in-upcoming-may-investor-conferences2025-05-07T12:01Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-reports-first-quarter-2025-financial-results2025-05-08T11:01Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-positive-long-term-results-from-phase-2-helios-clinical-trial-of-amx0035-in-people-with-wolfram-syndrome2025-05-12T11:00Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-to-participate-in-upcoming-june-investor-conferences2025-05-21T11:10Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-receives-us-fda-fast-track-designation-for-amx0114-for-the-treatment-of-amyotrophic-lateral-sclerosis2025-06-03T11:00Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-to-host-event-to-discuss-post-bariatric-hypoglycemia-and-avexitide-at-endo-20252025-07-08T11:00Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-presents-new-exploratory-analyses-from-phase-2-and-phase-2b-clinical-trials-of-avexitide-in-post-bariatric-hypoglycemia-at-endo-20252025-07-13T21:00Zyearly https://www.amylyx.com/jessicas-PBH-story2025-10-09T04:40Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-to-report-second-quarter-2025-financial-results-on-august-7-20252025-07-31T13:00Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-reports-second-quarter-2025-financial-results2025-08-07T11:00Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-to-participate-in-upcoming-investor-conferences-22025-08-26T13:02Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-to-discontinue-orion-program-of-amx0035-for-progressive-supranuclear-palsy-psp2025-08-27T11:01Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-proposed-public-offering-of-common-stock-02025-09-09T20:10Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-pricing-of-175-million-underwritten-public-offering-of-common-stock2025-09-10T04:10Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-to-report-third-quarter-2025-financial-results-on-november-6-20252025-10-30T13:00Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-to-present-at-upcoming-investor-conferences2025-11-03T14:01Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-reports-third-quarter-2025-financial-results2025-11-06T12:00Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-new-safety-and-tolerability-cohort-1-data-of-amx0114-in-als-from-first-in-human-lumina-trial2025-12-05T14:00Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-nomination-of-amx0318-as-a-novel-long-acting-glp-1-receptor-antagonist-development-candidate-identified-in-collaboration-with-gubra-a/s2026-01-08T13:19Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-to-report-fourth-quarter-and-full-year-2025-financial-results-on-march-3-20262026-02-24T14:01Zmonthly https://www.amylyx.com/news/amylyx-pharmaceuticals-reports-fourth-quarter-and-full-year-2025-financial-results2026-03-03T12:01Zmonthly https://www.amylyx.com/news/amylyx-pharmaceuticals-to-participate-in-upcoming-march-investor-conferences-22026-03-03T12:01Zmonthly https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-completion-of-enrollment-in-pivotal-phase-3-lucidity-clinical-trial-of-avexitide-in-post-bariatric-hypoglycemia2026-03-24T11:00Zdaily https://www.amylyx.com/open-positions2025-01-07T03:51Zyearly https://www.amylyx.com/contact2024-12-26T04:58Zyearly https://www.amylyx.com/partner-with-us2026-02-04T04:15Zmonthly https://www.amylyx.com/our-company2026-03-24T11:04Zdaily https://www.amylyx.com/news2024-12-31T10:46Zyearly https://www.amylyx.com/science2026-03-03T12:03Zmonthly https://www.amylyx.com/terms-of-use2025-01-07T03:50Zyearly https://www.amylyx.com/privacy-notice2025-01-07T03:48Zyearly https://www.amylyx.com/subscribe2024-12-31T05:48Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-participants-dosed-in-the-global-phase-3-phoenix-study-of-amx0035-in-als2023-04-03T05:39Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-submits-new-drug-application-nda-for-amx0035-for-the-treatment-of-als2023-04-03T05:38Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-hires-stephanie-hoffmann-gendebien-mba-as-head-general-manager-emea2023-04-03T05:39Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-plan-to-submit-new-drug-application-nda-for-amx0035-for-the-treatment-of-als-in-the-coming-months2023-04-03T05:39Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-donates-centaur-clinical-trial-data-and-participant-samples-to-help-advance-science-in-als-for-future-treatments-and-discoveries2023-04-03T05:39Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-health-canada-accepts-for-review-the-new-drug-submission-for-amx0035-for-the-treatment-of-als2023-04-03T05:39Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-closes-135m-series-c-financing-led-by-viking-global-investors-to-support-late-stage-development-of-lead-product-candidate-amx0035-for-the-treatment-of-als2023-04-03T05:39Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-strengthens-board-of-directors-with-appointment-of-daphne-quimi-chief-financial-officer-of-amicus-therapeutics2023-04-03T05:40Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-files-new-drug-submission-for-amx0035-for-the-treatment-of-als-in-canada2023-04-03T05:40Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-presents-trial-design-of-global-phase-3-phoenix-study-of-amx0035-in-als-at-the-european-network-to-cure-als-encals-meeting-20212023-04-03T05:40Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-provides-global-regulatory-update-on-amx00352023-04-03T05:36Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-to-present-centaur-long-term-survival-data-of-amx0035-for-als-in-plenary-session-at-2021-virtual-american-academy-of-neurology-aan-annual-meeting2023-04-03T05:40Znever https://www.amylyx.com/news/paul-fonteyne-joins-amylyx-pharmaceuticals-board-of-directors2023-04-03T05:40Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-plans-regulatory-filing-of-amx0035-for-the-treatment-of-als-in-canada2023-04-03T05:40Znever https://www.amylyx.com/news/amylyx-supports-rare-disease-day-and-showyourstripes-campaign-to-raise-awareness-for-rare-disease-communities2023-04-03T05:35Znever https://www.amylyx.com/news/james-frates-joins-amylyx-pharmaceuticals-as-chief-financial-officer2023-04-03T05:40Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-appoints-erin-whitney-head-of-global-clinical-operations-shauna-horvath-head-of-global-marketing-and-keith-white-head-of-global-market-access2023-04-03T05:40Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-to-present-positive-functional-and-survival-data-and-new-predictive-modeling-results-from-the-centaur-trial-in-people-with-als-at-the-31st-international-symposium-on-als-mnd2023-04-03T05:35Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-fda-granted-orphan-drug-designation-for-amx0035-for-the-treatment-of-wolfram-syndrome2023-04-03T05:41Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-last-patient-completes-final-study-visit-in-pegasus-trial-of-amx0035-in-alzheimers-disease2023-04-03T05:41Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-publication-of-centaur-survival-data-demonstrating-statistically-significant-survival-benefit-of-amx0035-for-people-with-als2023-04-03T05:41Znever https://www.amylyx.com/news/fierce-biotech-names-amylyx-pharmaceuticals-as-one-of-its-fierce-15-biotech-companies-of-20202023-04-03T05:41Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-new-england-journal-of-medicine-publication-of-pivotal-amx0035-data-demonstrating-statistically-significant-benefit-in-people-with-als2023-04-03T05:41Znever https://www.amylyx.com/news/tammy-sarnelli-joins-amylyx-pharmaceuticals-as-global-head-of-regulatory-affairs2023-04-03T05:41Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-raises-30-million-in-series-b-funding2023-04-03T05:41Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-completion-of-enrollment-in-the-pegasus-trial-of-amx0035-in-alzheimers-disease2023-04-03T05:41Znever https://www.amylyx.com/news/machelle-manuel-ph-d-joins-amylyx-pharmaceuticals-as-vice-president-head-of-global-medical-affairs2023-04-03T05:35Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-gets-inkedforals2023-04-03T05:42Znever https://www.amylyx.com/news/european-medicines-agency-grants-orphan-drug-designation-to-amylyx-pharmaceuticals-amx0035-for-the-treatment-of-amyotrophic-lateral-sclerosis-als2023-04-03T05:42Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-appoints-jeffrey-trigilio-chief-financial-officer2023-04-03T05:42Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-amx0035-demonstrated-statistically-significant-treatment-benefit-for-people-with-als-in-the-centaur-trial-22023-04-03T05:35Znever https://www.amylyx.com/news/amylyx-announces-appointment-of-debra-canner-as-global-head-of-human-resources-22023-04-03T05:35Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-last-patient-completes-last-study-visit-in-centaur-phase-2-study-of-amx0035-in-als-22023-04-03T05:36Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-strengthens-leadership-team-with-the-appointments-of-chief-medical-officer-chief-commercial-officer-and-global-head-supply-chain-22023-04-03T05:36Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-first-patients-dosed-in-pegasus-phase-2-trial-of-amx0035-in-alzheimers-disease-and-expansion-of-the-trial-22023-04-03T05:36Znever https://www.amylyx.com/news/innovative-alzheimers-disease-combination-therapy-trial-supported-by-new-joint-funding-initiative-22023-04-03T05:36Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-receives-fda-orphan-drug-designation-for-amx0035-for-the-treatment-of-amyotrophic-lateral-sclerosis-22023-04-03T05:36Znever https://www.amylyx.com/news/project-als-and-amylyx-enter-collaboration-to-test-amx0035-22023-04-03T05:37Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-results-from-pegasus-trial-of-amx0035-in-alzheimers-disease-at-the-clinical-trials-on-alzheimers-disease-ctad-conference2023-04-03T05:37Znever https://www.amylyx.com/community2025-10-09T04:39Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-submits-marketing-authorization-application-maa-for-amx0035-for-the-treatment-of-als2023-04-03T05:37Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-launch-of-initial-public-offering2023-04-03T05:37Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-fda-acceptance-and-priority-review-of-new-drug-application-nda-for-amx0035-for-the-treatment-of-als2023-04-03T05:37Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-pricing-of-upsized-initial-public-offering-of-common-stock2023-04-03T05:37Znever https://www.amylyx.com/news/the-canadian-neuromuscular-disease-registry-and-amylyx-pharmaceuticals-partner-on-real-world-evidence-generation-for-a-novel-investigational-therapy-in-als-with-the-goal-of-advancing-health-outcomes-for-canadians-living-with-als2023-04-03T05:37Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-to-present-at-the-11th-annual-svb-leerink-global-healthcare-conference2023-04-03T05:33Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-fda-advisory-committee-meeting-to-review-new-drug-application-for-amx0035-for-the-treatment-of-als-scheduled-for-march-30-20222023-04-03T05:33Znever https://www.amylyx.com/careers2025-12-18T04:21Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-expands-executive-team-with-appointment-of-gina-m-mazzariello-as-chief-legal-officer-and-general-counsel2023-04-03T05:33Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-ema-validation-of-marketing-authorisation-application-maa-for-amx0035-for-the-treatment-of-als2023-04-03T05:33Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-launch-of-us-expanded-access-program-for-amx00352023-04-03T05:33Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-posting-of-briefing-documents-for-fda-advisory-committee-meeting-on-amx00352023-04-03T05:32Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-outcome-of-fda-advisory-committee-meeting-on-amx0035-for-the-treatment-of-als2023-04-03T05:32Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-reports-full-year-2021-financial-results2023-04-03T05:31Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-oral-presentation-of-safety-and-tolerability-data-on-amx0035-from-clinical-trials-at-2022-american-academy-of-neurology-annual-meeting2023-04-03T05:31Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-publication-of-new-centaur-trial-analyses-further-demonstrating-significant-survival-benefit-with-amx0035-in-people-with-als2023-04-03T05:31Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-reports-first-quarter-2022-financial-results2023-04-03T05:31Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-publication-of-data-showing-randomization-to-amx0035-prolonged-tracheostomy/ventilation-free-survival-and-reduced-occurrence-of-first-hospitalization2023-04-03T05:31Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-presentation-of-new-analysis-of-centaur-trial-results-at-the-european-network-to-cure-als-2022-meeting2023-04-03T05:30Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-receives-notification-of-pdufa-date-extension-for-amx0035-for-the-treatment-of-als2023-04-03T05:30Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-health-canada-approval-of-albriozatm-for-the-treatment-of-als2023-04-03T05:30Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-fda-plan-to-reconvene-advisory-committee-to-review-amx0035-nda-for-the-treatment-of-als-on-september-7-20222023-04-03T05:30Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-to-announce-plans-for-an-open-label-extension-ole-phase-for-global-phoenix-trial-of-amx0035-in-als-at-the-17th-international-congress-on-neuromuscular-diseases2023-04-03T05:29Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-partnership-agreement-with-sunnybrook-research-institute-to-identify-novel-drug-candidates-for-neurodegenerative-diseases2023-04-03T05:29Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-albriozatm-is-now-available-in-canada-for-the-treatment-of-als2023-04-03T05:29Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-fda-advisory-committee-will-reconvene-to-review-new-drug-application-for-amx0035-for-the-treatment-of-als-on-september-7-20222023-04-03T05:29Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-reports-second-quarter-2022-financial-results2023-04-03T05:25Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-posting-of-briefing-documents-for-second-fda-advisory-committee-meeting-on-amx00352023-04-03T05:25Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-fda-advisory-committee-supports-approval-of-amx0035-for-the-treatment-of-als2023-04-03T05:25Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-donated-centaur-clinical-trial-data-now-available-to-help-advance-science-in-als-for-future-treatments-and-discoveries2023-04-03T05:25Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-publication-of-preclinical-data-showing-potential-synergistic-effect-of-amx0035-compared-to-individual-compounds2023-04-03T05:25Znever https://www.amylyx.com/social-media-guidelines2025-10-29T04:23Zyearly https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-closing-of-upsized-public-offering-of-common-stock-and-full-exercise-of-underwriters-option-to-purchase-additional-shares2023-04-03T05:24Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-pricing-of-upsized-public-offering-of-common-stock2023-04-03T05:24Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-launch-of-public-offering2023-04-03T05:24Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-announces-fda-approval-of-relyvriotm-for-the-treatment-of-als2023-04-03T05:23Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-to-report-third-quarter-2022-financial-results-on-november-10-20222023-07-11T10:33Znever https://www.amylyx.com/news/amylyx-pharmaceuticals-reports-third-quarter-2022-financial-results2023-04-03T05:23Znever https://www.amylyx.com/pipeline2026-03-24T11:04Zdaily https://www.amylyx.com/news/amylyx-pharmaceuticals-to-participate-in-the-evercore-isi-5th-annual-healthconx-conference2023-04-03T05:23Znever https://www.amylyx.com/corporate-compliance2024-04-04T12:03Zyearly https://www.amylyx.com/publications2022-12-07T04:16Znever